1. Time to treatment disparities in gastric cancer patients in the United States of America: a comprehensive retrospective analysis
- Author
-
Seema Sharan, Shivam Bansal, Harsheen Kaur Manaise, Paola Berrios Jimenez, Swathi R. Raikot, Syeda Hoorulain Ahmed, Reed Popp, Kyle Popp, Kulkaew Sukniam, Gabrielle Kowkabany, Fatima Mubarak, and Emmanuel Gabriel
- Subjects
time to treatment ,gastric cancer ,disparities ,disparities in treatment ,cancer ,sociodemographic factors ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
IntroductionGastric cancer ranks as the 5th most prevalent cancer and the 4th leading cause of cancer-related deaths worldwide. Various treatment modalities, including surgical resection, chemotherapy, and radiotherapy, are available for gastric cancer patients. However, disparities related to age, sex, race, socioeconomic factors, insurance status, and demographic factors often lead to delayed time to treatment.MethodsIn this retrospective study, conducted between 2004 and 2019, we utilized data from the National Cancer Database (NCDB) to investigate the factors contributing to disparities in the time to first treatment, surgery, chemotherapy, and radiotherapy among gastric cancer patients. Our analysis incorporated several variables, and statistical analysis was conducted to provide valuable insights into these disparities.ResultsWe observed notable disparities in the timing of treatment for various demographic groups, including age, sex, race, insurance status, geographic location, and facility type. These disparities include longer time to treatment in males (32.67 vs 30.75), Native Americans (35.10 vs 31.09 in Asians), low-income patients (32 vs 31.15), patients getting treatment in an academic setting (36.11 vs 29.61 in community setting), significantly longer time to chemotherapy in 70+ age group (51.13 vs 40.38 in
- Published
- 2024
- Full Text
- View/download PDF